Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VAMP4 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | SLC17A2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | AFG3L2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | TSPAN4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | RAB9A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | POU3F1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | ZC3HAV1L | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | FAM98A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | AC100821.1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | ARHGAP25 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |